News from saluda medical A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 13, 2023, 08:01 ET Saluda Medical Announces $150M Equity Financing Led by Wellington Management with Fidelity Management & Research Company and TPG

Saluda Medical Inc. ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of...

Mar 22, 2023, 09:00 ET EVOKE Presentation Awarded Overall Winner at ASIPP Annual Meeting

Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation, today announced that the ...

Jan 17, 2023, 09:00 ET Saluda Medical Announces Presentation of 36-Month Trial Data at NANS 2023 Annual Meeting

Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation, today announced that...

Dec 15, 2022, 16:01 ET Saluda Medical Initiates U.S. Commercialization of the Evoke® Spinal Cord Stimulation System

Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation, today announced it has...

Nov 07, 2022, 09:00 ET CMS Grants Transitional Pass-Through (TPT) Payment for Saluda's Evoke® SCS System

Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation, announced the Centers...

Oct 25, 2022, 09:00 ET Saluda Medical Surpasses Milestone: Measuring One Trillionth ECAP From Patients with the Evoke® System

Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation, today announced it has...

Oct 04, 2022, 10:00 ET Saluda Medical Appoints Laureen DeBuono to Board of Directors

Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation with an emerging...

Jul 19, 2022, 09:00 ET Saluda Medical the First to Present 24-Month Holistic Response to Spinal Cord Stimulation

Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation with an emerging...

May 18, 2022, 09:00 ET Saluda Medical Announces Robust Scientific Presence at 2022 International Neuromodulation Society (INS) World Congress

Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation with an emerging...

Apr 20, 2022, 09:00 ET Saluda Medical Appoints Robert Palmisano to Board of Directors

Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation with an emerging...

Mar 08, 2022, 09:00 ET Saluda Medical Receives FDA Approval for the Evoke® Spinal Cord Stimulation System to Treat Chronic Intractable Pain

Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation with an emerging...

Mar 02, 2022, 09:00 ET Saluda Medical Announces $125M Equity Financing Led by Redmile Group LLC and New Investors Fidelity Management & Research Company LLC and T. Rowe Price Associates, Inc.

Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation with an emerging...

Feb 23, 2022, 09:00 ET Saluda Medical Appoints Doug Godshall as Chairman of the Board

Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company on a mission to revolutionize the field of neuromodulation with an...

Jan 10, 2022, 09:00 ET Publication of Two-Year EVOKE Double-Blind Randomized Controlled Trial Results in JAMA Neurology Demonstrate Sustained Superiority of Evoke® Closed-Loop over Open-Loop Spinal Cord Stimulation

Saluda Medical Pty Limited ("Saluda Medical"), a global company on a mission to revolutionize the field of neuromodulation with an emerging portfolio ...

Nov 16, 2021, 09:00 ET Saluda Medical Expands Executive Leadership Team with Vision for Growth

Saluda Medical Pty Limited ("Saluda Medical"), the pioneer in neuromodulation platform of closed-loop technologies designed to achieve unparalleled...

May 10, 2021, 08:30 ET Saluda Medical Announces Publication of 24-Month Spinal Cord Stimulation Results with the Evoke® System

Saluda Medical Pty Limited ("Saluda Medical"), the market leader in the development of closed-loop spinal cord stimulation (SCS) for the treatment of ...

Feb 12, 2021, 09:05 ET Saluda Medical Announces Executive Leadership Changes

Saluda Medical Pty Limited ("Saluda Medical"), the market leader in the development of novel closed-loop spinal cord stimulation (SCS) for the...

Jan 20, 2021, 15:16 ET Saluda Medical Announces Highlights from 2021 North American Neuromodulation Society (NANS) Meeting

Saluda Medical Pty Limited ("Saluda Medical"), the market leader in the development of closed-loop spinal cord stimulation for the treatment of...

Jan 07, 2021, 09:00 ET Saluda Medical Announces Scientific Presentations at 2021 North American Neuromodulation Society (NANS) Meeting

Saluda Medical Pty Limited ("Saluda Medical"), developer of the Evoke® Closed-Loop Spinal Cord Stimulation (SCS) System for the treatment of chronic...

Dec 22, 2020, 08:00 ET NICE Publishes Briefing on Saluda's Evoke Closed-Loop Spinal Cord Stimulation (SCS) System

Saluda Medical Pty Limited ("Saluda Medical") announced today that the UK's National Institute for Health and Care Excellence (NICE) issued a Medtech ...

Jun 09, 2020, 08:00 ET Saluda Medical Appoints Jim Schuermann as President and Robert Gaffney as Chief Operating Officer

Saluda Medical Pty Limited ("Saluda Medical"), a global neuromodulation company leading the development and commercialization of data-driven,...

Jan 28, 2020, 17:45 ET Saluda Medical Publiceert Definitieve Langetermijnresultaten na 24 Maanden Avalon-studie en Resultaten na 12 Maanden Evoke Hoofdstudie in de V.S.

Saluda Medical Pty Limited ("Saluda Medical") heeft vandaag bekendgemaakt dat nieuwe data zijn gepresenteerd uit meerdere studies ter evaluatie van...

Jan 22, 2020, 05:21 ET Saluda Medical Belicht Meerdere Presentaties Over het Evoke® ECAP-Controlled, Closed-Loop SCS-Systeem op NANS Jaarcongres

Saluda Medical Pty Limited ("Saluda Medical") heeft vandaag bekendgemaakt dat data uit meerdere studies die een beoordeling geven van het Evoke®...

Jan 21, 2020, 07:00 ET Saluda Medical Highlights Multiple Presentations Featuring Evoke® ECAP-Controlled, Closed-Loop SCS System at NANS Annual Meeting

Saluda Medical Pty Limited ("Saluda Medical") today announced that data from multiple studies evaluating the company's Evoke® ECAP-Controlled,...

Dec 23, 2019, 00:14 ET Saluda Medical's Resultaten in Amerikaanse Evoke Hoofdstudie Gepubliceerd in The Lancet Neurology

Saluda Medical Pty Limited ("Saluda Medical") maakte vandaag bekend dat het tijdschrift The Lancet Neurology de resultaten heeft gepubliceerd van een ...